CSX Cash & Equivalents increased by 43.9% to $964.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 15.4%, from $1.14B to $964.00M. Over 5 years (FY 2020 to FY 2025), Cash & Equivalents shows a downward trend with a -26.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher levels indicate strong liquidity and financial flexibility; lower levels may signal potential cash flow issues.
This represents the most liquid assets held by the company, including cash on hand, demand deposits, and short-term inve...
A universal metric for assessing a company's immediate financial health.
cash_and_equivalents| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.99B | $2.18B | $2.24B | $1.94B | $724.00M | $2.31B | $1.93B | $1.29B | $956.00M | $1.36B | $1.35B | $1.48B | $1.24B | $1.64B | $933.00M | $1.14B | $387.00M | $612.00M | $670.00M | $964.00M |
| QoQ Change | — | -27.0% | +2.8% | -13.5% | -62.6% | +219.2% | -16.4% | -33.2% | -25.9% | +42.3% | -0.5% | +9.6% | -16.5% | +32.8% | -43.2% | +22.1% | -66.0% | +58.1% | +9.5% | +43.9% |
| YoY Change | — | — | — | — | -75.8% | +6.1% | -13.7% | -33.3% | +32.0% | -41.2% | -30.0% | +14.9% | +29.5% | +20.9% | -31.0% | -23.2% | -68.7% | -62.8% | -28.2% | -15.4% |